Skip to main content
Premium Trial:

Request an Annual Quote

But the Real Question Is, Would Jenny McCarthy Use Them?

The Wall Street Journal has an article about using genomics to develop vaccines -- something that Novartis in particular has been developing. A vaccine for a certain form of meningitis, for instance, is showing promise in clinical trials and "Novartis plans to move [it] into a much-larger test involving thousands of children next year, says Rino Rappuoli, an Italian scientist who heads Novartis's vaccine research," according to the article.

 

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.